Anti-Human Kappa Light Chain antibody [RM126]
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(2 Publications)
- Recombinant format for unrivalled batch-batch consistency
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Human Kappa Light Chain antibody [RM126] (AB195576)
Immunohistochemical analysis of Human tonsil tissue labeling Human IgG Kappa Light Chain with ab195576 at 2 μg/ml.
- ELISA
Lab
ELISA - Anti-Human Kappa Light Chain antibody [RM126] (AB195576)
The wells were coated with ab195576 at 0.5μg/ml at 50μl/well overnight at 4°C, followed by a 5% BSA blocking step for 2h RT. Human IgG (ab98981) was then added starting at 10 μg/ml and plasma/serum at 1 : 10 and gradually diluted 1 : 4, 50μl/well for 2h. Rabbit monoclonal [H19-5] Anti-Human kappa light chain (Biotin) (ab201484) was then added at 1 : 10,000 dilution, 50μl/well for 2h. A HRP-streptavidin (ab7403) was used at 1 : 10,000 dilution for 1h.
Reactivity data
Product details
Anti-Human Kappa Light Chain antibody [RM126] (ab195576) is a rabbit recombinant monoclonal antibody and is validated for use in Immunohistochemistry (IHC-P), ELISA in Human samples.
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Oncotarget 15:124-133 PubMed38329728
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of Alzheimer's disease : JAD 92:1077-1091 PubMed36847005
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com